Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation

This research was supported through a grant from the Canadian Institute of Health Research (CIHR) Drug Safety and Effectiveness Network (Funding reference number – 116573) and received financial support from the Canadian Agency for Drugs and Technologies in Health. CC is a recipient of a Vanier Canada Graduate Scholarship through CIHR (Funding reference number – CGV 121171) and has received funding from Canadian Network and Centre for Trials Internationally (CANNeCTIN). He is also a trainee on the CIHR Drug Safety and Effectiveness Network team grant (Funding reference number – 116573). MC is a recipient of a New Investigator Award from the Heart and Stroke Foundation of Canada and holds a T2 research chair in cancer and thrombosis from the University of Ottawa.